Technical Analysis for VXRT - Vaxart, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Earnings Movers | Other | 0.00% | |
| BB Squeeze + Lower Band Touch | Range Contraction | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | -0.78% | |
| Bollinger Band Squeeze | Range Contraction | -0.78% |
| Alert | Time |
|---|---|
| Possible Pocket Pivot | about 16 hours ago |
| Lower Bollinger Band Support | about 18 hours ago |
| 60 Minute Opening Range Breakdown | about 20 hours ago |
| 2x Volume Pace | about 20 hours ago |
| 1.5x Volume Pace | about 20 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 10/31/2024
Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Vaccines Influenza Coronavirus Hepatitis B Vaccination Papillomavirus Seasonal Influenza HPV Human Papilloma Virus Human Papillomavirus Infection Vaccine Preventable Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Vaccines Influenza Coronavirus Hepatitis B Vaccination Papillomavirus Seasonal Influenza HPV Human Papilloma Virus Human Papillomavirus Infection Vaccine Preventable Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.54 |
| 52 Week Low | 0.52 |
| Average Volume | 1,323,575 |
| 200-Day Moving Average | 0.88 |
| 50-Day Moving Average | 0.84 |
| 20-Day Moving Average | 0.79 |
| 10-Day Moving Average | 0.79 |
| Average True Range | 0.05 |
| RSI (14) | 41.86 |
| ADX | 13.16 |
| +DI | 15.10 |
| -DI | 22.18 |
| Chandelier Exit (Long, 3 ATRs) | 0.71 |
| Chandelier Exit (Short, 3 ATRs) | 0.87 |
| Upper Bollinger Bands | 0.83 |
| Lower Bollinger Band | 0.75 |
| Percent B (%b) | 0.06 |
| BandWidth | 9.73 |
| MACD Line | -0.01 |
| MACD Signal Line | -0.01 |
| MACD Histogram | -0.0021 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.87 | ||||
| Resistance 3 (R3) | 0.87 | 0.84 | 0.85 | ||
| Resistance 2 (R2) | 0.84 | 0.81 | 0.84 | 0.85 | |
| Resistance 1 (R1) | 0.80 | 0.79 | 0.78 | 0.80 | 0.84 |
| Pivot Point | 0.76 | 0.76 | 0.75 | 0.76 | 0.76 |
| Support 1 (S1) | 0.72 | 0.73 | 0.70 | 0.72 | 0.68 |
| Support 2 (S2) | 0.68 | 0.71 | 0.68 | 0.67 | |
| Support 3 (S3) | 0.65 | 0.68 | 0.66 | ||
| Support 4 (S4) | 0.64 |
